Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indonesia therapeutic efficacy study of dihydroartemisinin + piperaquine for uncomplicated malaria
ACTRN12622000248763Phase 4Completed
- Sponsor
- World Health Organization
- Start
- Nov 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dihydroartemisinin and piperaquine in Malaria and malaria, sponsored by World Health Organization. Primary endpoints: Treatment failure rate, Adequate clinical and parasitological response and 1 more. Started Nov 2020; status: completed.
02
Drugs
dihydroartemisininpiperaquine
03
Conditions
Malariamalaria
Beyond the preview
Go deeper on ACTRN12622000248763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000248763.